Clinical Trial Update: Early and Standard Intervention With 120,000 Units of PROCRIT (Epoetin Alfa) Every Three Weeks in Patients Receiving Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial assessing early and standard intervention with 120,000 units of epoetin alfa (PROCRIT) given every three weeks in chemotherapy patients with anemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• PROCRIT (ERYTHROPOIETIN)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anemia | Phase 2 | Status: COMPLETED